发行人将按上述票面利率于2026年1月22日至2026年1月23日面向专业机构投资者网下发行。 广发証券(01776)发布公告，广发证券股份有限公司(以下简称"发行人")面向专业机构投资者公开发行面 值余额不超过300亿元(含)的短期公司债券已获得中国证券监督管理委员会证监许可〔2025〕818号文同 意注册。广发证券股份有限公司2026年面向专业投资者公开发行短期公司债券(第一期)(以下简称"本期 债券")计划发行规模为不超过30亿元(含)。 2026年1月21日，发行人和主承销商在网下向专业机构投资者进行了票面利率询价，利率询价区间为 1.20%-2.20%。根据网下向专业机构投资者询价结果，经发行人与簿记管理人按照有关规定，在利率询 价区间内协商一致，最终确定本期债券(债券简称："26广发D1"，债券代码：524639)票面利率为 1.68%。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 GF SECURITIES CO., LTD. 廣發証券股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：1776） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條刊發。 根據中華人民共和國的有關法例規定，廣發証券股份有限公司（「本公司」）在深圳 證券交易所網站( http://www.szse.cn )刊發的《廣發証券股份有限公司2026年面向專 業投資者公開發行短期公司債券（第一期）票面利率公告》。茲載列如下，僅供參 閱。 承董事會命 廣發証券股份有限公司 林傳輝 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 广发证券股份有限公司（以下简称"发行人"）面向专业机构投资者公开发 行面值余额不超过 300 亿元（含）的短期公司债券已获得中国证券监督管理委员 会证监许可〔2025〕818 号文同意注册。广 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 GF SECURITIES CO., LTD. 廣發証券股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：1776） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條刊發。 根據中華人民共和國的有關法例規定，廣發証券股份有限公司（「本公司」）在深圳 證券交易所網站( http://www.szse.cn )刊發的《關於延長廣發証券股份有限公司2026 年面向專業投資者公開發行短期公司債券（第一期）簿記建檔時間的公告》。茲載 列如下，僅供參閱。 承董事會命 廣發証券股份有限公司 林傳輝 董事長 中國，廣州 2026年1月21日 於本公告日期，本公司董事會成員包括執行董事林傳輝先生、秦力先生、孫曉燕 女士及肖雪生先生；非執行董事李秀林先生、尚書志先生及郭敬誼先生；獨立非 執行董事梁碩玲女士、黎文靖先生、張闖先生及王大樹先生。 关于延长广发证券股份有限公司 （本 ...

证券代码：524639 证券简称：26 广发 D1 广发证券股份有限公司 2026 年面向专业投资者公开发行短期公司债券（第一期） 票面利率公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 广发证券股份有限公司（以下简称"发行人"）面向专业机构投资者公开发 行面值余额不超过 300 亿元（含）的短期公司债券已获得中国证券监督管理委员 会证监许可〔2025〕818 号文同意注册。广发证券股份有限公司 2026 年面向专 业投资者公开发行短期公司债券（第一期）（以下简称"本期债券"）计划发行规 模为不超过 30 亿元（含）。 2026 年 1 月 21 日，发行人和主承销商在网下向专业机构投资者进行了票面 利率询价，利率询价区间为 1.20%-2.20%。根据网下向专业机构投资者询价结果， 经发行人与簿记管理人按照有关规定，在利率询价区间内协商一致，最终确定本 期债券（债券简称："26 广发 D1"，债券代码：524639）票面利率为 1.68%。 （本页以下无正文） 1 （本页无正文，为《广发证券股份有限公司 2026 年面向专业投资者公开发行短 期公司债券 ...

证券时报·数据宝统计，截至1月21日收盘，深沪北共101只个股连续5日或5日以上主力资金净流入。杭 州银行等连续15日主力资金净流入，排名第一；云南白药连续13日主力资金净流入，位列第二。从主力 资金净流入总规模来看，德明利主力资金净流入金额最大，连续6天累计净流入15.50亿元，杭州银行紧 随其后，15天累计净流入14.39亿元。从主力资金净流入占成交额的比例来看，锋龙股份占比排名居 首，该股近15日上涨317.94%。（数据宝） 连续5日或以上主力资金净流入个股排名 | 证券代 | 证券简 | 主力资金净流入 | 主力资金净流入金额 | 主力资金净流入比例 | 累计涨跌幅 | | --- | --- | --- | --- | --- | --- | | 码 | 称 | 天数 | （亿元） | （%） | （%） | | 001309 | 德明利 | 6 | 15.50 | 6.77 | 22.39 | | 600926 | 杭州银 行 | 15 | 14.39 | 9.88 | -0.65 | | 000333 | 美的集 团 | 6 | 11.55 | 6.11 | 2.07 | | 000776 | ...

特此公告。 关于延长广发证券股份有限公司 2026 年面向专业投资者公开发行短期公司债券（第一期） 簿记建档时间的公告 广发证券股份有限公司（以下简称"发行人"）面向专业机构投资者公开发 行面值余额不超过 300 亿元（含）的短期公司债券已获得中国证券监督管理委员 会证监许可〔2025〕818 号文同意注册。 根据《广发证券股份有限公司 2026 年面向专业投资者公开发行短期公司债 券（第一期）发行公告》，发行人及簿记管理人原定于 2026 年 1 月 21 日 15:00-18:00 以簿记建档的方式向网下专业机构投资者进行利率询价，并根据簿记建档结果确 定本期债券的最终票面利率。 考虑到簿记建档当日市场情况，经发行人、簿记管理人及其他簿记参与方协 商一致，现将簿记建档结束时间由 2026 年 1 月 21 日 18:00 延长至 2026 年 1 月 21 日 19:00。 （以下无正文） 1 （本页无正文，为《关于延长广发证券股份有限公司 2026 年面向专业投资者公 开发行短期公司债券（第一期）簿记建档时间的公告》之盖章页） 华泰联合证券有限责任公司 年 月 日 3 （本页无正文，为《关于延长广发证券 ...

Core Viewpoint - The brokerage sector is currently experiencing a "lagging rise," with ROE on an upward trajectory, indicating that while the market performance is delayed, it is expected to improve significantly by 2025 [1] Group 1: Market Outlook - The capital market is projected to maintain high prosperity in 2025, with an average daily stock fund transaction volume of 20.8 trillion yuan, a year-on-year increase of 70.2% [1] - The average daily margin financing and securities lending balance is expected to reach 20.8 trillion yuan, reflecting a year-on-year growth of 32.7% [1] - The A-share IPO scale is anticipated to be 130.8 billion yuan, marking a year-on-year increase of 97.4% [1] Group 2: Financial Performance Projections - The brokerage sector (43 listed brokerages) is expected to see a 34% year-on-year increase in main revenue and a 49% increase in net profit attributable to shareholders in 2025 [2] - The projected net profit for key brokerages in 2025 includes: Guotai Junan (28.3 billion yuan, +117%), Dongfang Securities (6.1 billion yuan, +81%), and Zhongjin Company (8.8 billion yuan, +54%) [2] Group 3: Investment Business - The investment business is expected to perform steadily in Q4 2025, with total investment income projected to grow by 18% year-on-year [2] - The Shanghai Composite Index is expected to show a slight decline of 0.23% in Q4 2025, while the Wind All A Index is projected to increase by 0.97% [2] Group 4: Brokerage and Margin Financing Business - The average daily stock fund transaction volume in Q4 2025 is expected to reach 24.5 trillion yuan, a year-on-year increase of 16.8% [3] - The average daily margin financing balance is projected to be 24.9 trillion yuan, reflecting a year-on-year growth of 39.7% [3] Group 5: Investment Banking Business - The IPO financing scale in Q4 2025 is expected to be 54.9 billion yuan, a year-on-year increase of 165.1% [4] - The refinancing scale is projected to be 138.7 billion yuan, marking a year-on-year increase of 9.5% [4] Group 6: Asset Management Business - The total assets under management (AUM) for public funds are expected to be 37 trillion yuan, a 0.8% increase from the previous quarter [5] - The projected revenue growth for the asset management business in 2025 is expected to be 3% year-on-year [5]

Core Insights - Jilin Aodong Pharmaceutical Group Co., Ltd. has over 60 years of experience in the traditional Chinese medicine sector, focusing on the unique characteristics of the Changbai Mountain region and combining tradition with innovation to revitalize its brand [1][2] Group 1: Company Background and Development - The company originated from the state-owned Yanbian Dunhua Deer Farm established in 1957, forming a deep connection with local medicinal materials [1] - Jilin Aodong has built the largest GAP-certified deer breeding base in Asia and a medicinal material base in Changbai Mountain, establishing a resource library and database for local medicinal materials [1] - The company aims to become a leading enterprise in northern Chinese medicinal materials through a comprehensive industrial layout, including seedling nurseries and demonstration bases [1] Group 2: Technological Innovation and Quality Control - Jilin Aodong is breaking through traditional bottlenecks in Chinese medicine by integrating modern technology, transitioning from "experience-based manufacturing" to "intelligent manufacturing" [1] - The company has obtained 525 certifications for traditional Chinese medicine formula granules and has established an advanced traceability system for the entire industry chain to ensure medication safety [1][2] Group 3: Financial Strategy and Market Position - The dual-driven model of "healthcare + financial capital" supports the company's long-term strategy and adaptation to industry changes [2] - As the largest shareholder of GF Securities, Jilin Aodong also holds significant stakes in Shanghai Pharmaceuticals, Nanjing Pharmaceutical, and Liaoning Chengda, creating a capital synergy network across finance, pharmaceuticals, retail, and distribution [2] - The financial sector provides stable cash flow that supports the pharmaceutical business, ensuring high-quality development [2] Group 4: Future Outlook - Jilin Aodong plans to continue deepening research on the modernization of traditional Chinese medicine and extending its industrial chain layout [2] - The company aims to integrate into the "Healthy China" initiative, leveraging Changbai Mountain's medicinal materials, technological innovation, and capital collaboration to enhance its brand and contribute to the revitalization of the traditional Chinese medicine industry [2]

Market Performance - The three major stock indices in Shanghai and Shenzhen opened lower on January 21, but quickly rebounded, with the Shenzhen Component Index and ChiNext Index rising over 1% during the session [1] - The Sci-Tech Innovation 50 Index showed strong performance, with notable gains from companies such as Longxin Technology (up 20%) and Haiguang Information (up over 12%) [1] - By midday, the Shanghai Composite Index was at 4120.10 points, up 0.16%, with a trading volume of approximately 729.9 billion yuan; the Shenzhen Component Index was at 14263.20 points, up 0.76%, with a trading volume of about 901 billion yuan [1] Sector Performance - Key sectors that performed well included precious metals, epoxy propane, generator concepts, energy metals, and storage chips, while coal, electric grid equipment, and commercial retail sectors saw declines [1] - By midday, the precious metals, CPO concept, and lithium sectors were leading in gains, while coal, duty-free shops, and liquor sectors were among the biggest losers [1] Industry Insights - According to CITIC Securities, the storage chip sector is experiencing a price increase due to surging AI demand and supply-side contractions, leading to a performance boom for global storage industry companies [2] - Huatai Securities noted that after a significant increase in A-share trading volume, market sentiment remains high, with potential upward movement if supported by fundamental and liquidity catalysts [2] - GF Securities highlighted that the domestic new drug sector is entering a new growth cycle, with expectations for record-high License out transactions by 2025, showcasing the global competitiveness of domestic new drugs [2] Technological Developments - The Ministry of Industry and Information Technology reported that over 300 key technologies have been developed in the first phase of 6G technology trials, with expectations for industrial value-added growth of 5.9% by 2025 [3] - The ministry also emphasized the importance of supporting local governments in establishing future industry pilot zones and promoting new emerging industries [4][5]

2026年1月21日早盘，AI芯片、存储芯片等概念涨幅居前，截至10:04，中证人工智能主题指数(930713) 强势上涨2.07%，成分股澜起科技上涨10.26%，恒玄科技上涨5.29%，景嘉微上涨4.62%，芯原股份，中 科曙光等个股跟涨。人工智能ETF万家(159248)上涨2.22%。 人工智能ETF万家近3天获得连续资金净流入，最高单日获得649.16万元净流入，合计"吸金"1136.22万 元。 近期，AI基础设施建设加速推进，Meta正式成立"Meta Compute"新部门统筹全球数据中心群与供应商合 作，目标在本十年内建成数十吉瓦、最终达数百吉瓦级AI算力设施；与此同时，Cerebras斩获OpenAI超 100亿美元合作大单，承诺2028年前提供750兆瓦算力支持，凸显头部AI企业对异构算力供给的迫切需 求与长期投入决心。 政策面方面，工业互联网政策体系全面升级，"AI+制造"三大专项行动密集落地，涵盖《"人工智能+制 造"专项行动实施意见》《推动工业互联网平台高质量发展行动方案（2026—2028年）》《工业互联网 和人工智能融合赋能行动方案》，明确2027年推出1000个高水平工业智能 ...